Characteristics of participants included in the assessment of concordance between prenatal prognosis and postnatal neurodevelopmental outcome
| Characteristic | (n = 104) | GA <25 Weeks (n = 50) | GA ≥25 Weeks (n = 54) |
|---|---|---|---|
| GA at fetal MR imaging (range) (median) (IQR) (wk) | 19.00–39.43 (26.1 [21.8, 31.9]) | 19.00–24.43 (21.7 [21.0, 23.0]) | 25.00–39.43 (31.9 [29.6–34.0]) |
| Maternal age at fetal MR imaging (range) (median) (IQR) (yr) | 16.00–41.00 (31.0 [28.0–33.0]) | 16.00–41.00 (30.0 [28.0–32.0]) | 17.00–41.00 (31.0 [28.0–34.0]) |
| Age at postnatal visit (range) (median) (IQR) (yr) | 1.00–10.42 (3.0 [1.9–5.9]) | 1.00–8.92 (2.8 [1.7–5.1]) | 1.00–10.42 (3.8 [2.0–6.0]) |
| Brain region (No.) (%) | |||
| Ventriculomegaly | 32 (30.8%) | 17 (34.0%) | 15 (27.8%) |
| Mild | 20 (19.2%) | 12 (24.0%) | 8 (14.8%) |
| Moderate | 5 (4.8%) | 3 (6.0%) | 2 (3.7%) |
| Severe | 7 (6.7%) | 2 (4.0%) | 5 (9.3%) |
| Posterior fossa | 19 (18.3%) | 7 (14.0%) | 12 (22.2%) |
| Corpus callosum | 11 (10.6%) | 2 (4.0%) | 9 (16.7%) |
| Sulcation/migration | 8 (7.7%) | 5 (10.0%) | 3 (5.6%) |
| Normal | 28 (26.9%) | 18 (36.0%) | 10 (18.5%) |
| Space | 4 (3.8%) | 1 (2.0%) | 3 (5.6%) |
| Vascular anomaly | 1 (1.0%) | 0 (0.0%) | 1 (1.9%) |
| Hemorrhage | 1 (1.0%) | 0 (0.0%) | 1 (1.9%) |